Who is Roman Greifeneder


Aime
Roman Greifeneder is a seasoned medical device industry professional with a wealth of experience spanning over two decades. His career has been instrumental in shaping the landscape of medical technology, particularly in the field of cardiac arrhythmia management. Here's a detailed overview of his career and contributions:
- Professional Experience:
- CEO & Regulatory at Micropace Pty Ltd: Roman has been the CTO since 2020, bringing his 29 years of experience to the role12.
- Previous Roles: He has held senior positions at companies like Khelix, Ventracor, and ResMed, contributing to their growth and development2.
- Industry Focus: His expertise lies in the development of innovative technologies for cardiac electrophysiology, including the creation of the OneStim device4.
- Contributions to Micropace:
- Innovation and Collaboration: Micropace is known for fostering innovation through adaptability, agility, and problem-solving, which aligns with Roman's approach to product development1.
- Product Development: Under his leadership, Micropace has developed tools that enable faster and easier procedures for clinicians, addressing the needs of patients with arrhythmias1.
- Global Reach: The company's products are supplied to over 60 countries, reflecting Roman's focus on global accessibility to quality healthcare13.
- Awards and Recognition: Micropace has achieved CE marks for its therapeutic and diagnostic EP class III ablation products, recognizing the company's commitment to product excellence4.
- Academic and Professional Network: Roman's educational background includes a Master's degree from the University for Continuing Education Krems and a Bachelor's from AGSM @ UNSW Business School2.
In summary, Roman Greifeneder is a distinguished leader in the medical device industry, with a strong track record of developing innovative solutions that improve patient outcomes. His work at Micropace Pty Ltd has been pivotal in advancing the field of cardiac arrhythmia diagnosis and management.
Source:
m
1.
About Micropace
more
less
Continue this conversation 

Explore
Screener
Analysis
Learn
Wiki